Another year, another successful British Watchmakers' Day ✓ Ben highlights the best watches he saw there ✓ Check them out! ✓ ...
Vertex Software faces strong competition and slower growth, leading to a neutral rating. See why VERX stock remains pricey ...
Analysts' ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) over the last quarter vary from bullish to bearish, as provided by 17 analysts. The table below summarizes their recent ratings ...
ICER's evaluation of Vertex Pharmaceuticals' non-opioid pain drug, Journavx, finds cost-effectiveness related to potential ...
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
Vertex Pharmaceuticals has analysts doing financial backflips as they boost its price targets, with Royal Bank of Canada ...
Despite a market bloodbath that left the S&P 500 down 4.84%, Vertex Pharmaceuticals managed a modest gain of 0.11%, flaunting resilience. The biotech firm outpaced the broader medical sector over the ...
Thankfully the symbols they use are (mostly) universal, so once you've learned what each represents (as we explain below) you shouldn't have any problems no matter what you find in your laundry basket ...
The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, March 17, 2025. REUTERS/Staff/File Photo World stock markets and oil prices tumbled and investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results